35.02

1.48% 0.51

Pre-market: 32.98 -2.04 -5.83%

Procept Biorobotics Corp (PRCT)

Overview News Price History Option Chain Financials Discussions Forecast

Procept Biorobotics Corp stock is traded at $35.02, with a volume of 2.53M. It is up +1.48% in the last 24 hours and down -2.64% over the past month. PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Previous Close:

$34.51

Open:

$34.45

24h Volume:

2.53M

Relative Volume:

2.14

Market Cap:

$1.95B

Revenue:

$249.12M

Net Income/Loss:

$-90.19M

P/E Ratio:

-20.60

EPS:

-1.7

Net Cash Flow:

$-88.21M

1W Performance:

-5.22%

1M Performance:

-2.64%

6M Performance:

-37.04%

1Y Performance:

-63.92%

1-Day Range:

$33.97

$35.70

1-Week Range:

$33.38

$37.11

52-Week Range:

$32.11

$103.81

Procept Biorobotics Corp Stock (PRCT) Company Profile

Name

Procept Biorobotics Corp

Sector

Healthcare (1135)

Industry

Medical Devices (145)

Phone

(650) 232-9832

Address

150 BAYTECH DRIVE, SAN JOSE

Employee

756

Twitter

Next Earnings Date

2024-10-28

Latest SEC Filings

PRCT's Discussions on Twitter

Compare PRCT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRCT Procept Biorobotics Corp	35.02	1.92B	249.12M	-90.19M	-88.21M	-1.70
ABT Abbott Laboratories	125.80	215.34B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	98.84	146.15B	19.35B	2.78B	3.49B	1.8696
SYK Stryker Corp	362.61	136.97B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	90.42	115.69B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	84.15	48.77B	5.88B	1.34B	577.90M	2.3455

Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-02-25	Upgrade	Oppenheimer	Perform → Outperform
Jul-09-25	Initiated	Stephens	Overweight
Jul-07-25	Initiated	Oppenheimer	Perform
Dec-02-24	Initiated	Morgan Stanley	Overweight
Nov-14-24	Initiated	Jefferies	Hold
Aug-11-23	Initiated	Piper Sandler	Overweight
May-31-23	Initiated	William Blair	Outperform
Oct-31-22	Initiated	BTIG Research	Neutral
Oct-25-22	Initiated	Truist	Buy
Sep-02-22	Initiated	Wells Fargo	Overweight
Jul-15-22	Initiated	KeyBanc Capital Markets	Overweight
Jun-23-22	Initiated	B. Riley Securities	Buy
Oct-11-21	Initiated	BofA Securities	Buy
Oct-11-21	Initiated	Cowen	Outperform
Oct-11-21	Initiated	Goldman	Neutral
Oct-11-21	Initiated	Guggenheim	Buy
Oct-11-21	Initiated	SVB Leerink	Outperform

View All

Procept Biorobotics Corp Stock (PRCT) Latest News

07:20 AM

Procept BioRobotics stock price target lowered to $55 at Leerink Partners - Investing.com UK

07:20 AM

01:25 AM